What is the official website of Eurofins Lancaster Laboratories ?

The official website of Eurofins Lancaster Laboratories is https://www.eurofinsus.com/biopharma-services/laboratories/lancaster-laboratories/.

What is Eurofins Lancaster Laboratories's cybersecurity risk score?

Eurofins Lancaster Laboratories has an AI-generated cybersecurity risk score of 764 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins Lancaster Laboratories experienced?

According to Rankiteo, Eurofins Lancaster Laboratories currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins Lancaster Laboratories been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins Lancaster Laboratories has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins Lancaster Laboratories have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins Lancaster Laboratories is not certified under SOC 2 Type 1.

Does Eurofins Lancaster Laboratories have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins Lancaster Laboratories does not hold a SOC 2 Type 2 certification.

Does Eurofins Lancaster Laboratories comply with GDPR ?

According to Rankiteo, Eurofins Lancaster Laboratories is not listed as GDPR compliant.

Does Eurofins Lancaster Laboratories have PCI DSS certification ?

According to Rankiteo, Eurofins Lancaster Laboratories does not currently maintain PCI DSS compliance.

Does Eurofins Lancaster Laboratories comply with HIPAA ?

According to Rankiteo, Eurofins Lancaster Laboratories is not compliant with HIPAA regulations.

Does Eurofins Lancaster Laboratories have ISO 27001 certification ?

According to Rankiteo,Eurofins Lancaster Laboratories is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins Lancaster Laboratories operate in ?

Eurofins Lancaster Laboratories operates primarily in the Biotechnology Research industry.

How many employees does Eurofins Lancaster Laboratories have ?

Eurofins Lancaster Laboratories employs approximately 3,135 people worldwide.

Does Eurofins Lancaster Laboratories own any subsidiaries ?

Eurofins Lancaster Laboratories presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins Lancaster Laboratories have ?

Eurofins Lancaster Laboratories's official LinkedIn profile has approximately 92,628 followers.

What is the NAICS classification code for Eurofins Lancaster Laboratories ?

Eurofins Lancaster Laboratories is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Eurofins Lancaster Laboratories have a Crunchbase profile ?

No, Eurofins Lancaster Laboratories does not have a profile on Crunchbase.

Does Eurofins Lancaster Laboratories have a LinkedIn profile ?

Yes, Eurofins Lancaster Laboratories maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/lancaster-laboratories.

How many cybersecurity incidents has Eurofins Lancaster Laboratories experienced ?

As of June 22, 2026, Rankiteo reports that Eurofins Lancaster Laboratories has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins Lancaster Laboratories have ?

Eurofins Lancaster Laboratories has an estimated 4,709 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ELL

Boost Score +25 with badge (5 left)

764

/1000

Fair

789

/1000

Fair

Eurofins Lancaster Laboratories Vendor Cyber Rating & Cyber Score

eurofinsus.com

Add Your Compliance Badge

Eurofins Lancaster Laboratories is one of the largest commercial contract laboratories in the world providing comprehensive laboratory services in the pharmaceutical, biopharmaceutical and environmental sciences, both in our laboratories and in our client facilities through our Professional Scientific Services (PSS) program. Our goal is to be the premier provider of laboratory services worldwide while delivering an outstanding service experience. We serve clients from a diverse range of businesses and industries including Fortune 100 Industrial companies, the world’s largest pharmaceutical/biopharmaceutical companies as well as virtual, small and mid-sized companies throughout the world. We also serve local and national governments. With

ELL A.I CyberSecurity Scoring

Scoring History

ELL

Eurofins Lancaster Laboratories CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

ELL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ELL

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins Lancaster Laboratories in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins Lancaster Laboratories in 2026.

Incident Types ELL vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Eurofins Lancaster Laboratories in 2026.

Incident History - ELL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins Lancaster Laboratories Subsidiaries

ELL

Biotechnology Research

Website: https://www.eurofinsus.com/biopharma-services/laboratories/lancaster-laboratories/

Company Size: 3,135

EurofinsBiotechnology Research

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins AdvinusResearch Services

Eurofins Discovery Services IndiaResearch

Eurofins Advinus Agrosciences IndiaResearch Services

Eurofins BioPharma Product Testing India Pharmaceutical Manufacturing

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins Agroscience ServicesResearch

Eurofins Agroscience Biological SolutionsResearch

Eurofins Agroscience Seed ServicesResearch Services

Eurofins Agroscience Regulatory ConsultancyResearch Services

Eurofins Agroscience Biological AssessmentResearch Services

Eurofins Agroscience Environmental SafetyResearch

Eurofins Agroscience Consumer/Human SafetyResearch Services

Eurofins Agroscience Product ChemistryResearch Services

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins Environment Testing (USA)Environmental Services

Eurofins GenomicsBiotechnology Research

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins DiscoverXBiotechnology Research

Eurofins Agro & HortiResearch Services

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Eurofins Danmark - LaboratoriumBiotechnology Research

Eurofins Product Testing Denmark A/SSecurity and Investigations

Eurofins Steins LaboratoriumBiotechnology Research

Eurofins Clinical DiagnosticsBiotechnology

Eurofins ViracorMedical and Diagnostic Laboratories

ExPeCT™ anti-CD19 (FMC63) CAR TMedical and Diagnostic Laboratories

Eurofins Viracor CMV TestingBiotechnology Research

TTViWATCH™ - Torque Teno Virus qPCRMedical and Diagnostic Laboratories

Eurofins ChileFood and Beverage Services

Eurofins Environment Testing FranceBiotechnology

Eurofins | Solutions DurablesServices de conseil en environnement

Eurofins Hygiène HospitalièreBiotechnology Research

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins Central LaboratoryBiotechnology Research

Eurofins DiscoveryBiotechnology

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Eurofins CDMOPharmaceutical Manufacturing

Eurofins CDMO AlphoraPharmaceutical Manufacturing

Eurofins BiomnisMedical and Diagnostic Laboratories

Eurofins Food AssuranceProfessional Services

Eurofins PSS Insourcing SolutionsBiotechnology Research

Loading…

Eurofins Lancaster Laboratories Similar Companies

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Loading…

NEWS

Eurofins Lancaster Laboratories CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 02, 2017 08:00 AM

Eurofins Adding 350 Jobs In Pennsylvania

The company will invest $59 million in the Lancaster County expansion project, which includes a new facility, laboratory instrumentation and...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-12814

SUMMARY

A flaw has been found in Comfast CF-WR631AX V3 up to 2.7.0.8. This issue affects the function system of the file /cgi-bin/mbox-config?section=ping_config of the component API Endpoint. This manipulation of the argument destination causes os command injection. The attack is possible to be carried out remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-21

Updated

Date2026-06-21

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-12813

SUMMARY

A vulnerability was detected in activepieces up to 0.83.0. This vulnerability affects the function handleUrlFile in the library packages/server/engine/src/lib/variables/processors/file.ts of the component File URL Handler. The manipulation results in server-side request forgery. The attack can be executed remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-21

Updated

Date2026-06-21

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-12812

SUMMARY

A security vulnerability has been detected in Radware Cyber Controller up to 10.11.0. This affects an unknown part of the component HTML Report Generation. The manipulation leads to HTML injection. Remote exploitation of the attack is possible. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-21

Updated

Date2026-06-21

RISK INFORMATION (Score: 3.5)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.1

REFERENCES

CVE-2026-12811

SUMMARY

A weakness has been identified in kortix-ai suna up to 0.8.38. Affected by this issue is the function router.replace/router.push of the file apps/frontend/src/app/auth/page.tsx of the component Auth Endpoint. Executing a manipulation of the argument returnURL can lead to cross site scripting. The attack may be launched remotely. The exploit has been made available to the public and could be used for attacks. Upgrading to version 0.8.39 can resolve this issue. This patch is called f5dec7aa0c1b8fa0125938f292c0f2430ca75f6c. It is advisable to upgrade the affected component. The researcher explains: "The issue was fixed in v0.8.39 without notifying the wider user base via a security disclosure."

Published

Date2026-06-21

Updated

Date2026-06-21

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-12810

SUMMARY

A security flaw has been discovered in Edimax BR-6478AC V2 1.23. Affected by this vulnerability is the function mp of the file /goform/mp of the component POST Request Handler. Performing a manipulation of the argument command results in command injection. The attack may be initiated remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-21

Updated

Date2026-06-21

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…